FDA Letter API

DFA Dairy Brands, LLC

Letter data

Company
DFA Dairy Brands, LLC
Recipient
Mr. Alan Bernon | CEO | DFA Dairy Brands, LLC | Friendly's Manufacturing and Retail LLC | 2711 North Haskell Ave | Suite 3400 | Dallas | , | TX | 75204 | United States
Issue date
2023-08-31
Posted date
Not available
FDA office
Office of Human and Animal Food Operations East - Division 1
Subject
Not available
Product
Food & Beverages
CMS ID
590821
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER DFA Dairy Brands, LLC MARCS-CMS 590821 — August 31, 2023 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA UNITED PARCEL SERVICE SIGNATURE REQUIRED Product: Food & Beverages Recipient: Recipient Name Mr. Alan Bernon Recipient Title CEO DFA Dairy Brands, LLC Friendly's Manufacturing and Retail LLC 2711 North Haskell Ave Suite 3400 Dallas , TX 75204 United States Issuing Office: Office of Human and Animal Food Operations East - Division 1 United States Dear Mr. Bernon: The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter 590821, issued on November 22nd, 2019 for your facility located at 1855 Boston Road, Wilbraham, MA 01095-1002. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Latoya Griffith Director, Compliance Branch Office of Human and Animal Food Operations East Division 1 Content current as of: 09/11/2023 Regulated Product(s) Food & Beverages